Opportunity in Crisis

Opportunity in Crisis

Membership required to view content.
 that they will seek approval for the newly developed COVID-19 vaccine is a shot in the arm for unsure global markets.  Today’s market activity reflects participants ambivalence, weighing the game changing vaccine with economic fallout from impending lockdown measures.  Pfizer’s collaboration has yielded a vaccine that is apparently over 90% effective, and safe. 

Pfizer says they will apply for Emergency Use Authorization (EUA) with the FDA imminently, after the required safety milestone is achieved.  Pfizer, with a $50 billion+ market cap has an historical working relationship with the FDA, having gained approval for some of the most widely used drugs, like Lipitor, Viagra, or Zoloft.  The vaccine trial began in…

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

01.22.2025

Be8, Cemvita to study glycerin-to-SAF feasibility in Brazil

Be8, Cemvita to study glycerin-to-SAF feasibility in Brazil

Brazilian biofuels producer Be8 and US-based biotech company Cemvita signed a memorandum of understanding to study the technical and economic feasibility of converting glycerin into sustainable aviation fuel (SAF),...

01.22.2025

CWG prices jump 17% from prior week on strong renewable demand

CWG prices jump 17% from prior week on strong renewable demand

The choice white grease (CWG) market continued to trade higher on Wednesday January 22 with deals done as high as 42 cents per lb FOB Missouri River, but the...

01.22.2025

US weekly wheat, soybean export inspections decline; corn up 7%

US weekly wheat, soybean export inspections decline; corn up 7%

Export inspections of US grains showed a decline for soybean and wheat, while corn increased in the week to January 16, according to data from the USDA released on...

Latest Tweets